GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cytosorbents
CytoSorbents produces a blood purification device used in intensive care. Its stock price reflects its slow adoption in medical practice. The chart tells the story of its struggle to gain widespread acceptance and approval for the treatment of sepsis and other serious conditions.
Share prices of companies in the market segment - Therapeutic medical equipment
CytoSorbents has developed and markets the CytoSorb medical device—a blood filter that removes excess cytokines and other inflammatory mediators in severe conditions such as sepsis. We've classified it in the "Therapeutic Medical Equipment" segment. The chart below shows the overall dynamics in the extracorporeal therapy sector.
Broad Market Index - GURU.Markets
CytoSorbents is a medical technology company that has developed a blood purification technology to remove excess inflammatory cytokines from critically ill patients. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medtech sector.
Change in the price of a company, segment, and market as a whole per day
CTSO - Daily change in the company's share price Cytosorbents
CytoSorbents Corporation's daily stock price reflects volatility in the medical device sector. The index is sensitive to news about the use of its blood purification technology in critical care.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
CytoSorbents Corporation is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to CTSO, which focuses on blood purification devices, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
CytoSorbents produces blood purification devices for critical care patients. It is an innovative company in the intensive care sector. Its stock price reflects progress in the implementation of breakthrough medical technologies and is part of the overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cytosorbents
Cytosorbents Corporation's year-over-year performance tells the story of its blood purification technology. Its market capitalization growth over the past 12 months reflects the increased use of its CytoSorb filter in European intensive care units for the treatment of sepsis and other critical conditions, as well as its years-long efforts to secure FDA approval in the US.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
CytoSorbents Corporation produces a unique medical device for blood purification in severe diseases. Its success depends on the widespread adoption of this innovative product in hospitals. The chart below shows how the market views its technology and its path to profitability in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
CytoSorbents, with its blood purification technology, is a high-risk, high-potential company. Its stock price is entirely dependent on the results of its clinical trials. The chart isn't about economics, but rather whether investors believe its revolutionary approach will become the new standard in intensive care.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cytosorbents
CytoSorbents produces blood purification devices. Its monthly performance reflects progress in the commercialization of its flagship product, CytoSorb. Key drivers include sales growth in Europe, news of clinical trials leading to FDA approval, and the expansion of its technology.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
The market for medical blood purification devices for critical care is an important niche in healthcare. Its market capitalization dynamics, shown in the graph, reflect the demand for innovative intensive care methods. Companies like Cytosorbents offer solutions in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
CytoSorbents, a manufacturer of blood purification devices, is at the intersection of medicine and technology. The company's stock moves on news of product approvals and rollouts. Its performance depends more on medical advances than on the state of the economy.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cytosorbents
Shares of Cytosorbents, a manufacturer of blood purification devices, react weekly to news about its use. Data on its use in sepsis or during complex surgeries, as well as regulatory approvals in new countries, trigger strong investor reactions.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Cytosorbents shares, like the entire innovative medical device sector, are moving on a backdrop of news about clinical trials and regulatory approvals. These factors create high volatility for everyone. The chart will show how the company fares in this risky field.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cytosorbents shares, like the entire innovative medical device sector, are moving on a backdrop of news about clinical trials and regulatory approvals. These factors create high volatility for everyone. The chart will show how the company fares in this risky field.
Market capitalization of the company, segment and market as a whole
CTSO - Market capitalization of the company Cytosorbents
The CytoSorbents market capitalization chart is a financial valuation of the company whose flagship product, CytoSorb, purifies blood of inflammatory cytokines. It reflects both its use in intensive care and the long road to approval in the US. Its dynamics are a story of balancing success in Europe with regulatory barriers in the US market.
CTSO - Share of the company's market capitalization Cytosorbents within the market segment - Therapeutic medical equipment
Cytosorbents developed and commercialized the CytoSorb medical device for purifying blood of excess inflammatory substances in sepsis and other critical conditions. Its market share reflects its pioneering status in this field. The chart below shows this innovator's presence in critical care.
Market capitalization of the market segment - Therapeutic medical equipment
CytoSorbents produces devices for purifying blood of inflammatory cytokines. The chart below shows the overall market capitalization of the therapeutic devices sector. Its dynamics reflect the search for solutions for critical conditions such as sepsis. CytoSorbents' technology has the potential to save lives in intensive care.
Market capitalization of all companies included in a broad market index - GURU.Markets
Blood purification is a cutting-edge field of medicine, as illustrated by the graph. CytoSorbents produces filters that remove excess inflammatory substances from the blood during sepsis and other critical conditions. Its capitalization is a bet that its technology will become the standard in intensive care.
Book value capitalization of the company, segment and market as a whole
CTSO - Book value capitalization of the company Cytosorbents
Cytosorbents' chart is the material basis for saving lives in intensive care. The growth in its book value reflects the expansion of its unique CytoSorb columns, which purify blood from "cytokine storms." These physical assets create a tool to combat sepsis.
CTSO - Share of the company's book capitalization Cytosorbents within the market segment - Therapeutic medical equipment
CytoSorbents produces unique blood purification devices. Its stake in the sector's assets lies in its manufacturing facilities in the United States. This physical base allows it to manufacture its flagship product, CytoSorb, which is used in intensive care units worldwide.
Market segment balance sheet capitalization - Therapeutic medical equipment
CytoSorbents Corporation produces medical devices for blood purification. Its business is moderately capital-intensive. The company requires its own manufacturing facilities to produce its CytoSorb columns. Compared to the medical device sector, this demonstrates that the production of innovative devices requires control over physical assets.
Book value of all companies included in the broad market index - GURU.Markets
CytoSorbents' assets are not drugs, but a unique blood purification device, similar to dialysis, that removes the "cytokine storm" associated with sepsis and other critical conditions. The company's balance sheet reflects the value of this vital technology. The chart shows the capital behind this blood "filter."
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cytosorbents
Cytosorbents produces a medical device for blood purification. Its market capitalization is based on the technology's potential to treat severe diseases such as sepsis. Investors are paying a premium for a unique product that has the potential to save lives and has no direct equivalent.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
CytoSorbents manufactures and markets a blood purification device used in intensive care. The company's value lies in its unique, patented product. This chart shows the market premium for its technology and its potential to become a standard of care for severe illnesses.
Market to book capitalization ratio for the market as a whole
Cytosorbents produces a medical device for blood purification in severe illnesses. As a medtech company, its valuation is based on its unique technology and patents. This chart shows the premium investors pay for an innovative medical product capable of saving the lives of critically ill patients.
Debts of the company, segment and market as a whole
CTSO - Company debts Cytosorbents
CytoSorbents produces a medical device for blood purification in severe diseases. Expanding its commercial presence in global markets and conducting clinical trials for new indications requires significant capital. Debt financing is a tool for accelerating this growth and market penetration.
Market segment debts - Therapeutic medical equipment
Cytosorbents Corporation produces medical devices for blood purification. After receiving marketing approval in Europe, the company is investing in commercial expansion and clinical trials to enter the US market. This chart shows how the company finances these costly parallel processes, balancing revenue with capital needs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cytosorbents
Cytosorbents produces medical devices for blood purification, which requires investment in clinical research and marketing. This chart shows the company's debt load. While borrowing helps expand the technology's applicability, the risks are high: if the product isn't included in treatment standards or competitors emerge, servicing the debt will become difficult.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
CytoSorbents has developed a blood purification technology used to remove excess inflammatory substances in severe illnesses such as sepsis. This chart compares the company's debt required to commercialize this vital technology to the overall market capitalization of the entire therapeutic medical device sector.
Debt to book value of all companies in the market
Cytosorbents produces medical devices for blood purification. Expanding international sales and conducting clinical trials requires funding. The chart shows how the company is using debt capital to support its growth. A comparison with the medical device sector allows us to assess the aggressiveness of its market capture strategy.
P/E of the company, segment and market as a whole
P/E - Cytosorbents
For Cytosorbents, a blood purification device manufacturer, this chart evaluates its application in critical care. The price-to-earnings ratio shows whether investors believe their technology will become the standard for treating sepsis and other serious conditions. The price-to-earnings ratio reflects clinical trial results and sales growth.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average valuation for medical device manufacturers—the benchmark for Cytosorbents. Comparing this metric helps investors understand how the market views the potential of the company's blood purification technology. A higher-than-average valuation may indicate confidence that it will become a new standard in intensive care.
P/E of the market as a whole
CytoSorbents has developed and markets a blood purification device that removes excess inflammatory substances. It is used in intensive care units to treat sepsis and other critical conditions. This chart reflects the state of the healthcare sector and helps understand how the adoption of this technology in hospitals worldwide is impacting the company's growth and valuation.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cytosorbents
CytoSorbents produces the CytoSorb blood purification device, which is used in intensive care to remove excess inflammatory cytokines. The company's future growth depends on the wider adoption of this technology in hospitals. This chart shows whether analysts believe CytoSorb therapy will become the standard of care for sepsis and other critical conditions.
%20P%2FE%20Cytosorbents&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Cytosorbents&v=1772555463281 "Chart of the company's future (projected) P/E Cytosorbents")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Cytosorbents has developed a medical device, CytoSorb, a blood filter that removes excess inflammatory substances during sepsis and other critical conditions. The chart shows how the company's revenue forecasts compare to the medical device industry average, reflecting the market's appreciation of its unique technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772555463293 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Cytosorbents has developed a blood purification technology for the treatment of life-threatening conditions. This chart shows the overall sentiment in the healthcare sector. For Cytosorbents, the key is not the economics but the adoption of their product in intensive care units around the world. This is a growth story based on saving lives, not economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772555463295 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Cytosorbents
CytoSorbents has developed and commercialized the CytoSorb medical device—a cartridge for purifying the blood of excess inflammatory substances in critically ill patients. This graph shows how demand for intensive care affects financial results. Profitability depends on the product's adoption in hospitals worldwide for the treatment of sepsis and other critical conditions.
Profit of companies in the market segment - Therapeutic medical equipment
CytoSorbents developed and markets the CytoSorb device, a blood purification cartridge that removes excess inflammatory mediators from critically ill patients, such as those with sepsis. This chart shows the overall profitability of the medical device sector, demonstrating how innovative critical care technologies are finding application in hospitals.
Overall market profit
CytoSorbents produces blood purification devices used in intensive care units. Demand for its products is driven by the number of critically ill patients and is independent of economic cycles. This makes the company's business non-cyclical and resilient. Hospitals need its products to save lives, regardless of the state of the economy.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cytosorbents
CytoSorbents produces a medical blood purification device used in intensive care units to treat severe conditions such as sepsis. This chart reflects analysts' expectations for the widespread adoption of this technology in clinical practice worldwide, which will determine future revenue.
%20profit%20of%20the%20company%20Cytosorbents&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Cytosorbents&v=1772555463436 "Graph of future (projected) profit of the company Cytosorbents")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
CytoSorbents produces blood purification devices that remove excess inflammatory substances, which are used in intensive care and cardiac surgery. This chart shows forecasts for the medical device sector. CytoSorbents' profitability depends on the expansion of its technology in hospitals worldwide and the demonstration of its clinical effectiveness.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772555463451 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
CytoSorbents produces blood purification devices used in intensive care. Demand for its products depends on hospital budgets and the frequency of critical illnesses. While demand is relatively stable, the overall economic situation, reflected in this chart, impacts healthcare system funding and their ability to purchase advanced medical equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772555463477 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Cytosorbents
CytoSorbents produces the CytoSorb medical device for purifying blood of excess inflammatory substances in sepsis and other critical conditions. This chart shows how investors view the company's revenue. The growth reflects the expanding use of its unique technology in intensive care units worldwide.
P/S market segment - Therapeutic medical equipment
CytoSorbents developed and markets CytoSorb, a blood purification device that removes excess cytokines and other inflammatory mediators in sepsis and other critical conditions. This chart shows the average rating for medical device manufacturers, helping to understand how the market views the potential of this life-saving technology compared to other products.
P/S of the market as a whole
CytoSorbents has developed and markets the CytoSorb device for purifying the blood of inflammatory cytokines in critically ill patients. It is an innovative product for intensive care. This chart shows the premium investors are willing to pay for the company's revenue, which offers a unique solution for saving lives in critical conditions.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cytosorbents
CytoSorbents manufactures and markets CytoSorb blood purification devices, which remove excess inflammatory substances from critically ill patients. This chart shows investor estimates for the company's future revenue. It reflects expectations for the device's increased use in intensive care units worldwide.
%20P%2FS%20Cytosorbents&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Cytosorbents&v=1772555463557 "The graph of the company's future (projected) P/S Cytosorbents")
Future (projected) P/S of the market segment - Therapeutic medical equipment
CytoSorbents produces a blood purification device used in intensive care units to remove excess inflammatory cytokines. This chart compares the company's estimated future sales with its industry sector. It reflects the market's assessment of the degree of acceptance of this technology by physicians for the treatment of critical conditions.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772555463599 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
CytoSorbents has developed and markets the CytoSorb medical device, designed to filter blood and remove excess inflammatory cytokines. The optimism expressed by this indicator is often fueled by medical breakthroughs. The increasing use of CytoSorb in intensive care is an indicator of advances in treatments for critical conditions such as sepsis.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772555463615 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Cytosorbents
Cytosorbents manufactures and markets the CytoSorb blood purification device. Revenue, shown in this chart, is generated from sales of these devices to hospitals for the treatment of critically ill patients with sepsis or inflammation. This growth reflects the expanding use of this therapy in intensive care units.
Sales of companies in the market segment - Therapeutic medical equipment
CytoSorbents has developed a unique blood purification device, CytoSorb, which removes excess inflammatory substances from critically ill patients. Their technology is used in intensive care units. This graph illustrates the growing medical device market, where life-saving products in critical situations have enormous potential.
Overall market sales
CytoSorbents Corporation produces blood purification devices used in intensive care. Demand for its products depends on hospital budgets and the frequency of critical patient events. The increase in overall economic revenue, reflected in this graph, improves healthcare system funding, allowing clinics to implement innovative technologies that save lives.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cytosorbents
Cytosorbents Corporation has developed and marketed the CytoSorb medical device—a blood purification cartridge that removes excess inflammatory substances from critically ill patients. This graph shows analysts' expectations for the adoption of this technology in intensive care units worldwide to combat sepsis and other conditions.
%20sales%20of%20the%20company%20Cytosorbents&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Cytosorbents&v=1772555463741 "Schedule of future (projected) sales of the company Cytosorbents")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
CytoSorbents has developed blood purification technology for the treatment of severe conditions such as sepsis and acute respiratory distress syndrome. Its flagship product, CytoSorb, removes excess cytokines. This chart shows forecasts for the medical device sector, illustrating the urgent need for new treatments for critical conditions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772555463761 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Cytosorbents, a manufacturer of blood purification devices, sees this chart as an indicator of intensive care unit utilization. While a direct correlation isn't obvious, the stable economy reflected here ensures sustainable hospital funding, allowing them to implement new technologies for treating critical conditions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772555463810 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Cytosorbents
CytoSorbents produces a medical blood purification device used in the treatment of critically ill patients. The company's profitability is directly dependent on sales volumes of this device to hospitals worldwide. This chart shows the progress of the commercialization of this vital technology and how revenues from it are converted into net profit.
Market segment marginality - Therapeutic medical equipment
Cytosorbents produces blood purification devices used in intensive care units to treat severe conditions. In critical care, profitability depends on clinical evidence and manufacturing efficiency. The chart shows how the company compares in operational efficiency with other medical device manufacturers.
Market marginality as a whole
CytoSorbents has developed a blood purification technology for the treatment of life-threatening conditions such as sepsis. Despite its overall profitability, CytoSorbents operates in the intensive care field. Their profitability depends on the adoption of their product in hospitals and proof of its effectiveness in saving patients' lives.
Employees in the company, segment and market as a whole
Number of employees in the company Cytosorbents
CytoSorbents produces a unique medical device for blood purification. This chart shows the size of its team, including production, research, and sales personnel. The growth of its staff, particularly its sales team, is directly related to the expanding use of its technology in intensive care units worldwide.
Share of the company's employees Cytosorbents within the market segment - Therapeutic medical equipment
CytoSorbents developed the CytoSorb blood purification technology, which is used in intensive care units to remove excess cytokines. This chart shows the percentage of specialists—from engineers to clinicians—the company attracts in the therapeutic medical equipment niche. This is a measure of its innovative contribution to the treatment of critical conditions.
Number of employees in the market segment - Therapeutic medical equipment
CytoSorbents produces a medical blood purification device used in intensive care to treat severe inflammatory conditions. The company's success depends on its sales team. This chart shows how the company is growing its sales. The growth in staff, particularly in the sales department, is an indicator of the adoption of its technology in hospitals worldwide.
Number of employees in the market as a whole
CytoSorbents produces blood purification devices for critical care patients. Demand for its products in intensive care units is independent of economic cycles. This graph reflects the health of the economy, but unfortunately, the need to treat sepsis and severe inflammation is always present, keeping the company going.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cytosorbents (CTSO)
Cytosorbents produces blood purification devices. This is a combination of R&D and high-tech manufacturing. This metric reflects the balance between the value of patents and the efficiency of production facilities. The graph shows how this balance changes as the company grows.
%20of%20the%20company%20Cytosorbents%20(CTSO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Cytosorbents-CTSO&v=1772555464149 "Chart of market capitalization per employee (in thousands of dollars) of the company Cytosorbents (CTSO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Cytosorbents produces blood purification devices used in intensive care. In the medical equipment sector, this metric reflects both the uniqueness of the technology and the effectiveness of its commercialization. The graph compares the company's market valuation per employee to that of other medical device manufacturers.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772555464174 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
CytoSorbents manufactures and markets a blood purification device used in intensive care to remove cytokines and other toxins. It is a MedTech company. This chart shows how the market values a business based on a unique, patented product that can save the lives of critically ill patients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772555464231 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cytosorbents (CTSO)
Cytosorbents produces a medical device (CytoSorb)—a blood filter that removes cytokines during surgery or sepsis. It's a therapeutic device. This graph shows how successfully the company is commercializing its product. It reflects how much profit each employee (salesperson, engineer) generates from the sale of this consumable.
%20Chart%20Cytosorbents%20(CTSO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Cytosorbents-CTSO&v=1772555464240 "Company Profit Per Employee (in thousands of dollars) Chart Cytosorbents (CTSO)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Cytosorbents (CTSO) manufactures and sells blood purification devices (hemoperfusion devices) used in intensive care to reduce cytokine storms. It is a medical device company. This chart shows the company's commercial performance. It reflects how successfully the sales team promotes their vital product to hospitals, generating revenue per employee.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772555464259 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Cytosorbents is a medical device company that produces the CytoSorb device for blood purification (hemoperfusion) in sepsis and other critical conditions. It is now a commercial company. This chart shows how successfully it is scaling sales of its product. Revenue per employee depends on production efficiency and the sales team's ability to convince hospitals to use this technology.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772555464288 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Cytosorbents (CTSO)
CytoSorbents produces a blood purification device used in intensive care. This chart shows how well their product is being adopted in hospitals worldwide. The increase in revenue per employee reflects increased sales of their vital product and the effectiveness of their marketing and distribution team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Cytosorbents-CTSO&v=1772555464330 "Sales chart per company employee Cytosorbents (CTSO)")
Sales per employee in the market segment - Therapeutic medical equipment
CytoSorbents produces blood purification devices (hemoperfusion) used in intensive care to remove cytokines and other toxins. It is a MedTech company. This chart shows the average revenue per employee in the sector. It helps assess how productive CytoSorbents' commercial team is in promoting its innovative, yet niche, product to hospitals worldwide.
Sales per employee for the market as a whole
CytoSorbents (CTSO) produces CytoSorb, a blood filter that removes cytokine storm and other inflammatory substances in critically ill patients (such as those with sepsis). This chart shows how successfully their commercial team sells this vital product to hospitals worldwide, based on the number of employees they employ.
Short shares by company, segment and market as a whole
Shares shorted by company Cytosorbents (CTSO)
CytoSorbents produces a medical device (CytoSorb) for blood filtration that removes cytokines during severe inflammation (sepsis, COVID-19). Despite years of effort, the company is struggling to achieve widespread adoption. The chart shows the number of investors betting that the company will never be able to prove the clinical and economic benefits of its product.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Cytosorbents-CTSO&v=1772555464529 "Short Shares Chart for the Company Cytosorbents (CTSO)")
Shares shorted by market segment - Therapeutic medical equipment
CytoSorbents produces blood purification filters (hemoperfusion) for intensive care units to combat cytokine storms. This indicator measures bearish sentiment in the sector. It rises when investors doubt the widespread clinical application of this technology or anticipate reimbursement issues for the entire blood purification industry.
Shares shorted by the overall market
CytoSorbents produces blood purification devices used in intensive care units. Although their products save lives, the company is still in a growth phase. This chart illustrates the general level of investor fear. Even healthcare companies like CTSO can come under pressure when the market anticipates a correction, as investors begin to doubt their speed to profitability.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cytosorbents (CTSO)
Cytosorbents produces blood purification devices, which are critical in intensive care. Demand for their products can spike during health crises. This indicator tracks the strength of price momentum, showing when investor expectations (above 70) are outpacing reality or when sell-offs (below 30) are creating excessive pessimism.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Cytosorbents-CTSO&v=1772555464647 "RSI 14 indicator chart for the company's stock Cytosorbents (CTSO)")
RSI 14 Market Segment - Therapeutic medical equipment
Cytosorbents (CTSO) are a "filter" for blood. Their specialty is *hemosorption* (CytoSorb): a *cartridge* that *removes* "cytokine storm" (inflammation) from blood in *intensive care*. The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI\_14\_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is CTSO's growth a niche product or a general "overheating"?
RSI 14 for the overall market
CytoSorbents (CTSO) produces blood purification devices. This chart reflects hospitals' willingness to implement expensive innovations. During periods of euphoria and budget increases, clinics eagerly purchase new technologies. During times of panic and cost-cutting, they may postpone CTSO implementation in favor of cheaper, standard methods.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CTSO (Cytosorbents)
Cytosorbents (CTSO) produces a device (CytoSorb) for blood purification ("hemofiltration") of cytokines in critically ill patients (sepsis, COVID-19). This graph shows the average 12-month forecast. It reflects analysts' expectations for the rate of adoption of this therapy in intensive care units.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CTSO-Cytosorbents&v=1772555464743 "A chart showing analyst consensus forecasts for the expected stock price. CTSO (Cytosorbents)")
The difference between the consensus estimate and the actual stock price CTSO (Cytosorbents)
Cytosorbents (CTSO) is a medtech company that created CytoSorb, a blood filter that removes cytokines during the "cytokine storm" associated with sepsis or COVID-19. This chart shows their "pivot" estimate. It measures the gap between the price and the consensus target, reflecting whether analysts believe they can prove efficacy and secure FDA approval.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CTSO-Cytosorbents&v=1772555464756 "A chart showing the difference between the consensus forecast and the actual stock price. CTSO (Cytosorbents)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
CytoSorbents is a medical device company that produces a "blood filter" (CytoSorb) that removes excess cytokines (called "cytokine storms") during sepsis and severe infections. This chart shows general expectations for the therapeutic medical device sector. It reflects whether experts believe the extracorporeal therapy market will grow.
Analysts' consensus forecast for the overall market share price
Cytosorbents produces a "blood filter" for treating critical conditions (sepsis). This is an R&D/commercial story that burns through cash. This chart, reflecting the market's "risk appetite," is vital. When optimism is high, investors fund "game-changing" medical technologies. When pessimism ("risk-off") takes over, investors flee unprofitable medtech companies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cytosorbents
CytoSorbents is a MedTech company that has developed a blood filter (CytoSorb). It's an extracorporeal therapy device used in intensive care to remove cytokine storm and other toxins from the blood during sepsis and burns. This chart summarizes their R&D and commercialization. It reflects their sales in Europe (where it's approved) and their long road to approval in the US (FDA).
AKIMA Market Segment Index - Therapeutic medical equipment
Cytosorbents (CTSO) developed CytoSorb blood purification technology. This filter removes excess cytokines and other inflammatory mediators from critically ill patients (e.g., those with sepsis). The chart shows the average index for the segment, helping investors assess how successfully CTSO is commercializing its life-saving technology compared to the sector average.
The AKIM Index for the overall market
CytoSorbents is a MedTech company that produces blood adsorbers (CytoSorb) for removing toxins and cytokines from critically ill patients. This chart, which reflects the market average, is a backdrop. It helps assess how this critical care technology compares to overall macroeconomic trends and clinical data.
